|Owning department||Department of Biology & Biochemistry|
|Notional study hours||300|
|Level||FHEQ level 7|
|Availability||Optional unit on MSc Molecular Biosciences (Medical Biosciences)|
This optional unit is for students interested in contemporary cancer research and the challenges and opportunities in developing treatments for cancer.
Topics covered include the genetic hallmarks of cancer development such as viral/non-viral oncogenesis, angiogenesis and metastasis, followed by conventional (radio/chemotherapy) and rationalised therapies for cancer such as gene-based targeted approaches and immunotherapies.
You'll learn how to:
- read broadly across the literature to gain a thorough knowledge of the molecular and micro-environmental differences between cancer and normal tissues
- analyse how these differences are exploited in drug design for cancer treatment
- present research seminars critically evaluating current and emerging therapies for cancer.
After successfully completing this unit, you should be able to:
- demonstrate a strong understanding of the core molecular genetics underpinning the development, progression and spread of cancers, applying this understanding in original ways
- critically evaluate and communicate the findings from cutting-edge research publications through formal presentation
- demonstrate an integrative and critically evaluative approach to conventional and rationalised cancer therapies.